latest news releases from the newsroom
CON-SPACE Communications Ltd.
New President for CON-SPACE
RICHMOND, British Columbia, Jan. 4, 2007 (PRIME NEWSWIRE) -- CON-SPACE Communications Ltd. (TSX-V:CCB), (http://www.con-space.com ), a world leader in specialized voice communication products, today announced the appointment of Mr. Michael Thirlwell, as the new company President.
MedaSorb Announces IDE Filing With the FDA
MONMOUTH JUNCTION, N.J., Jan. 4, 2007 (PRIME NEWSWIRE) -- MedaSorb Technologies Corporation (OTCBB:MSBT) today announced that is has submitted an Investigational Device Exemption (IDE) Supplement to the FDA for its CytoSorb(tm) hemoperfusion blood filtration device. The IDE application addresses the use of CytoSorb(tm) for the treatment of Acute Respiratory Distress Syndrome (ARDS) caused by sepsis. The filing, which includes a proposed pilot study, was delivered to the FDA on December 29, 2006. If the proposed pilot study is approved by the FDA, MedaSorb intends to commence clinical trials by the third quarter of 2007.